This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 10 EPO patents. Top assignees: Organes Tissus Régénération Réparation Remplacement, Centre National De La Recherche Scientifique, Université De Caen Normandie. Active years: 2026.
Company Filing History:
2 out of 2 
1 out of 122 
1 out of 23 Years Active: 2026
Title: Denis Barritault: Innovator in Angiogenesis Research
Introduction
Denis Barritault is a notable inventor based in France, recognized for his contributions to the field of angiogenesis research. His work primarily focuses on peptide fragments that have significant implications for treating various proliferative disorders, including cancer.
Latest Patents
Denis Barritault holds a patent titled "Peptide Fragments Of The Harp Factor Inhibiting Angiogenesis." This invention concerns peptide fragments 13-39 and 65-97 of the HARP factor, which inhibit angiogenesis. Advantageously, these peptides can be associated with the peptide 111-136 of HARP. The invention also includes pharmaceutical compositions comprising these peptides or nucleic acids encoding them, along with their use for treating pathologies associated with angiogenesis.
Career Highlights
Denis Barritault is affiliated with the Centre National de la Recherche Scientifique, where he conducts his research and development activities. His innovative work has contributed to the understanding and potential treatment of diseases linked to abnormal blood vessel growth.
Collaborations
Denis has collaborated with notable colleagues, including Isabelle Pierrot and Pierre Milhiet, who have contributed to his research endeavors.
Conclusion
Denis Barritault's work in peptide research and angiogenesis has the potential to impact the treatment of serious health conditions. His innovative contributions continue to advance the field of medical research.